Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc > Proof of old adage. Bad news travels third class

<< Previous

Bullboard Posts

Next >>

Comment by Majictraderon Jan 18, 2021 5:26pm

135 Views

Post# 32322653

RE:RE:RE:Proof of old adage. Bad news travels third class

Agreed. Own vxl for a while now. Will take some money near the upcoming event :). Cph still have quite a bit after the cut as well, so will hold. I think there should be some clarity on marketing n all now that this episode is somewhat over. If bausch was looking to buy them out then 1.50 or 1.25 is what cph holder may get. Else we wait for good news on US sales n marketing partner. Lesson, keep taking profits :). Good luck all.

<< Previous

Bullboard Posts

Next >>

Three junior copper stocks for the long run